Their quantitative predictivity, sensitivity and specificity are difficult to state, but they probably give about 80% correct negative results, i.e., sensitization is unlikely (Kimber & Maurer, 1996) and about 60% correct positive predictions, i.e., skin sensitization is likely to occur
The medication isnt failing
As USP takes effect from 1 December 2025, there will be clear guidelines in place for drug manufacturers to demonstrate suitability of intended use of packaging materials and delivery systems through comprehensive system-based functional testing
GLP-1 receptor agonists also reduce the three components of MACE, including CV mortality (reduced by 13%), nonfatal stroke (reduced by 16%) and nonfatal myocardial infarction (reduced by 9%, although the level of significance was not reached)
FDA approves first oral GLP-1 treatment for type 2 diabetes. September 20, 2019